Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder

OBJECTIVE: To study rituximab in pediatric neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) and the relationship between rituximab, B cell repopulation, and relapses in order to improve rituximab monitoring and redosing. METHODS: Multicenter retrospective study of 16 children with NMO/NMOSD...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurol Neuroimmunol Neuroinflamm
Asıl Yazarlar: Nosadini, Margherita, Alper, Gulay, Riney, Catherine J., Benson, Leslie A., Mohammad, Shekeeb S., Ramanathan, Sudarshini, Nolan, Melinda, Appleton, Richard, Leventer, Richard J., Deiva, Kumaran, Brilot, Fabienne, Gorman, Mark P., Waldman, Amy T., Banwell, Brenda, Dale, Russell C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4723136/
https://ncbi.nlm.nih.gov/pubmed/26819962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000188
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller